Cleveland Clinic and G42, a global leader in artificial intelligence (AI), said they will collaborate to drive AI-powered advancements in healthcare.
As part of this initiative, the two will form a joint task force to evaluate, prioritize and accelerate potential projects and collaborative opportunities aimed at advancing AI adoption in healthcare.
Cleveland Clinic’s AI-driven future
The collaboration envisages G42 and Cleveland Clinic exploring and implementing transformative AI-driven healthcare initiatives that have the potential to redefine patient care, enhance medical innovation, and drive operational efficiencies.
The efforts are expected to benefit not only the UAE and the wider region, but extend globally, shaping the future of healthcare through intelligent, data-driven solutions.
“AI’s potential to transform the healthcare industry remains largely untapped,” said Peng Xiao, Group CEO of G42.
“From deciphering the source code of life – our genome – to optimising efficiencies across the entire patient journey, AI is paving the way for a future where care is not only more precise but also deeply personalised and preventative,” he said.
Xiao said the company looks forward to embarking on this journey alongside Cleveland Clinic and other global partners, harnessing AI to unlock new frontiers in medicine, empower clinicians with unprecedented insights, and ultimately, reshape the way humanity experiences health and longevity.
Tom Mihaljevic, CEO and President of Cleveland Clinic, said the healthcare company is committed to finding opportunities that improve patient safety, patient experience, patient outcomes and access.
“Artificial intelligence offers a tremendous opportunity to continue to advance and fulfill our mission of caring for life, researching for health and educating those who serve,” said Mihaljevic, who is also the Morton L. Mandel CEO Chair.
G42, a technology group headquartered in Abu Dhabi, is known for its advanced innovation in AI, digital infrastructure, and big data analytics solutions across a wide range of industries. Its healthcare portfolio company spanning 480 clinics in 26 countries, M42, leads some of the most groundbreaking health advancements in the industry, such as the Emirati Genome Program, the world’s largest genomics initiative, and Malaffi, Abu Dhabi’s Health Information Exchange.
Cleveland Clinic, which has a unit in Abu Dhabi, is a global health system that includes 23 hospitals and 280 outpatient facilities.
Follow us on
